** Shares of medical imaging software provider ImExHs
IME.AX rise as much as 3.7% to A$0.425, set to mark their best
day since Feb 7, if trend holds
** Co says unit RIMAB won contract with Colombia-based
insurance provider Famisanar
** Says deal is expected to contribute an estimate A$1.1 mln
($743,270.00) in annual recurring revenue
** Under deal, co will perform Famisanar's MRI studies for
patients across the Cundinamarca region
** Stock hits highest level since Feb 20
** IME down ~10.9% so far this year, as of last close
($1 = 1.4799 Australian dollars)
(Reporting by Upasana Singh in Bengaluru)
((Upasana.Singh@thomsonreuters.com))